Case Reports
doi: 10.1016/j.jns.2007.02.027.
Epub 2007 Mar 23.
Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
Affiliations
- PMID: 17382963
- DOI: 10.1016/j.jns.2007.02.027
Item in Clipboard
Case Reports
Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
J Neurol Sci.
.
Abstract
The authors report a 57-year-old patient with chronic inflammatory demyelinating polyneuropathy (CIDP) associated with diabetes mellitus (DM) who was treated successfully with rituximab. The B lymphocyte suppression using rituximab was followed 4 weeks later by neurological improvement and a stable disease course of over 10 months. We suggest that rituximab may be a treatment option in CIDP increasingly less responsive to intravenous immunoglobulin, particularly in patients with concurrent DM.
Similar articles
-
Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody.J Clin Neurosci. 2006 Jul;13(6):683-7. doi: 10.1016/j.jocn.2005.09.008. Epub 2006 Jun 30. J Clin Neurosci. 2006. PMID: 16814550
-
Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura.Muscle Nerve. 2008 Aug;38(2):1076-7. doi: 10.1002/mus.21073. Muscle Nerve. 2008. PMID: 18642360 No abstract available.
-
Chronic inflammatory demyelinating polyneuropathy associated with intestinal tuberculosis.J Microbiol Immunol Infect. 2007 Aug;40(4):377-80. J Microbiol Immunol Infect. 2007. PMID: 17712474
-
Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.Semin Arthritis Rheum. 2005 Dec;35(3):175-84. doi: 10.1016/j.semarthrit.2005.08.008. Semin Arthritis Rheum. 2005. PMID: 16325658 Review.
-
Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.Expert Rev Neurother. 2006 Mar;6(3):365-79. doi: 10.1586/14737175.6.3.365. Expert Rev Neurother. 2006. PMID: 16533141 Review.
Cited by
-
Treatment of chronic inflammatory demyelinating polyneuropathy.Curr Neurol Neurosci Rep. 2015 Jul;15(7):47. doi: 10.1007/s11910-015-0563-z. Curr Neurol Neurosci Rep. 2015. PMID: 26008811 Review.
-
Practical considerations on the use of rituximab in autoimmune neurological disorders.Ther Adv Neurol Disord. 2010 Mar;3(2):93-105. doi: 10.1177/1756285609356135. Ther Adv Neurol Disord. 2010. PMID: 21179602 Free PMC article.
-
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Cochrane Database Syst Rev. 2017 May 8;5(5):CD003280. doi: 10.1002/14651858.CD003280.pub5. Cochrane Database Syst Rev. 2017. PMID: 28481421 Free PMC article.
-
Advances in the diagnosis, pathogenesis and treatment of CIDP.Nat Rev Neurol. 2011 Aug 16;7(9):507-17. doi: 10.1038/nrneurol.2011.121. Nat Rev Neurol. 2011. PMID: 21844897 Review.
-
An update on the management of chronic inflammatory demyelinating polyneuropathy.Ther Adv Neurol Disord. 2012 Nov;5(6):359-73. doi: 10.1177/1756285612457215. Ther Adv Neurol Disord. 2012. PMID: 23139706 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
